Interprofessional Webinar Series:
Assessment and Management of Fatigue in Medical Illness
This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.
Funding Disclosure: No commercial funding has been accepted for the activity.
Date and Time: December 3, 2015, 12:30 PM – 1:30 PM ET (Live)
Location: Online at https://www.mjhspalliativeinstitute.org/e-learning/
Speaker Name and Title:
Pauline Lesage, MD, LLM
MJHS Institute for Innovation in Palliative Care
New York, NY
Purpose: The purpose of this webinar is to clarify and improve our knowledge of a common but not well understood topic in palliative care: the assessment and management of fatigue in medical illness.
Objectives: Participants will be able to:
- Discuss the definition, epidemiology and etiology of fatigue in various medical illnesses.
- Describe the complexity of fatigue through its pathophysiology.
- Identify and evaluate non-pharmacologic and pharmacologic approaches to fatigue management.
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students
Criteria for Successful Completion:
- Attendance at entire session (mandatory for nurses, social workers, pharmacists)
- Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs, nurses, social workers)
- Successful completion of a posttest; 80% passing grade (mandatory to receive CE credit for social workers)
- Submission of completed Verification of Continuing Education Participation Form, Program Evaluation Form, and CE Validation Form (mandatory for pharmacists). Pharmacists must email all three forms to Shelita Clark at email@example.com or fax forms to 212-649-5544 within 45 days of webinar date.
Continuing Education Credits: 1.0
Continuing Education Accreditation:
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.
NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.
NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.
Social Workers: NHPCO is an approved provider of continuing education contact hours by the National Association of Social Workers (Provider #886414158).
This educational activity has been submitted for approval for 1.0 hours.
Pharmacists: St. John’s University College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this program provides a total of 1.0 hours of home-study continuing education credit. In order to obtain credit, participants must complete and submit required continuing education forms. The Universal Activity Number assigned to this program is: #0043-9999-15-118-H01-P. Credit will be posted to CPE Monitor within six weeks.
Individual: $25 (includes CME/CE certificate)
Group: $65 + $5 per CME/CE certificate
Registration fees for webinars are not refundable.
Pauline Lesage, MD, LLM, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Russell K. Portenoy, MD, Planner, has indicated a relationship with Pfizer Inc. for research grant support.
No other Planning Committee Member has any disclosures.
Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny